List of Scholar Rock patents

Patents where

Current Assignee

Name

Scholar Rock

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11365245 LTBP complex-specific inhibitors of TGFβ and uses thereof	Patent 11365245 was granted and assigned to Scholar Rock on June, 2022 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	11365245	June 21, 2022
‌ US Patent 11643459 TGFβ1-binding immunoglobulins and use thereof	Patent 11643459 was granted and assigned to Scholar Rock on May, 2023 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	11643459	May 9, 2023
‌ US Patent 9758576 Compositions and methods for growth factor modulation	Patent 9758576 was granted and assigned to Scholar Rock on September, 2017 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	9758576	September 12, 2017
‌ US Patent 9399676 Compositions and methods for growth factor modulation	Patent 9399676 was granted and assigned to Scholar Rock on July, 2016 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	9399676	July 26, 2016
‌ US Patent 9573995 Compositions and methods for growth factor modulation	Patent 9573995 was granted and assigned to Scholar Rock on February, 2017 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	9573995	February 21, 2017
‌ US Patent 10946036 Use of myostatin inhibitors and combination therapies	Patent 10946036 was granted and assigned to Scholar Rock on March, 2021 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	10946036	March 16, 2021
‌ US Patent 11439704 Methods for using anti-myostatin antibodies	Patent 11439704 was granted and assigned to Scholar Rock on September, 2022 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	11439704	September 13, 2022
‌ US Patent 11155611 Compositions and methods for making and using anti-myostatin antibodies	Patent 11155611 was granted and assigned to Scholar Rock on October, 2021 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	11155611	October 26, 2021
‌ US Patent 10287345 Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodies	Patent 10287345 was granted and assigned to Scholar Rock on May, 2019 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	10287345	May 14, 2019
‌ US Patent 9758577 Compositions and methods for growth factor modulation	Patent 9758577 was granted and assigned to Scholar Rock on September, 2017 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	9758577	September 12, 2017
‌ US Patent 10882904 Methods for inhibiting myostatin activation by administering anti-pro/latent myostatin antibodies	Patent 10882904 was granted and assigned to Scholar Rock on January, 2021 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	10882904	January 5, 2021
‌ US Patent 10981981 Compositions and methods for growth factor modulation	Patent 10981981 was granted and assigned to Scholar Rock on April, 2021 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	10981981	April 20, 2021
‌ US Patent 9580500 Compositions and methods for growth factor modulation	Patent 9580500 was granted and assigned to Scholar Rock on February, 2017 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	9580500	February 28, 2017
‌ US Patent 11135291 Methods for making and using anti-myostatin antibodies	Patent 11135291 was granted and assigned to Scholar Rock on October, 2021 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	11135291	October 5, 2021
‌ US Patent 10307480 Anti-pro/latent-myostatin antibodies and uses thereof	Patent 10307480 was granted and assigned to Scholar Rock on June, 2019 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	10307480	June 4, 2019
‌ US Patent 11214614 LTBP complex-specific inhibitors of TGFβ and uses thereof	Patent 11214614 was granted and assigned to Scholar Rock on January, 2022 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	11214614	January 4, 2022
‌ US Patent 10597443 Compositions and methods for growth factor modulation	Patent 10597443 was granted and assigned to Scholar Rock on March, 2020 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	10597443	March 24, 2020
‌ US Patent 10751413 Anti-pro/latent-Myostatin antibodies and uses thereof	Patent 10751413 was granted and assigned to Scholar Rock on August, 2020 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	10751413	August 25, 2020
‌ US Patent 11130803 Isoform-selective TGFβ1 inhibitors and use thereof	Patent 11130803 was granted and assigned to Scholar Rock on September, 2021 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	11130803	September 28, 2021
‌ US Patent 12006359 Methods for altering body composition by administering anti-pro/latent myostatin antibodies	Patent 12006359 was granted and assigned to Scholar Rock on June, 2024 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	12006359	June 11, 2024
‌ US Patent 12122823 Isoform-selective TGFB1 inhibitors and use thereof	Patent 12122823 was granted and assigned to Scholar Rock on October, 2024 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	12122823	October 22, 2024
‌ US Patent 11925683 Compositions for making and using anti-Myostatin antibodies	Patent 11925683 was granted and assigned to Scholar Rock on March, 2024 by the United States Patent and Trademark Office.	Scholar Rock	Scholar Rock	United States Patent and Trademark Office	11925683	March 12, 2024

22 results

0 selected

22 results

0 selected